Viome Life Sciences has a total of 39 patents globally, out of which 1 has been granted. Of these 39 patents, more than 7% patents are active. United States of America is where Viome Life Sciences has filed the maximum number of patents, followed by Europe and China. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Viome Life Sciences.
Viome Life Sciences was founded in the year 2016. The Company provides scientific discovery, research, and development services for health and chronic disease.
Do read about some of the most popular patents of Viome Life Sciences which have been covered by us in this article and also you can find Viome Life Sciences patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Viome Life Sciences patent portfolio.
How many patents does the founder and the CEO of Viome Life Sciences have?
The founder and CEO Naveen Jain has 0 patent.
How many patents does Viome Life Sciences have?
Viome Life Sciences has a total of 39 patents globally. These patents belong to 23 unique patent families. Out of 39 patents, 3 patents are active.
How Many Patents did Viome Life Sciences File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Viome Life Sciences Applications Filed | Viome Life Sciences Patents Granted |
| 2023 | 1 | – |
| 2021 | 1 | – |
| 2020 | 6 | – |
| 2019 | 5 | – |
| 2018 | 11 | 1 |
| 2017 | 10 | – |
| 2016 | 2 | – |
| 2015 | 1 | – |
| 2013 | 2 | – |
How many Viome Life Sciences patents are Alive/Dead?
How Many Patents did Viome Life Sciences File in Different Countries?
Countries in which Viome Life Sciences Filed Patents
| Country | Patents |
| United States Of America | 7 |
| Europe | 5 |
| China | 5 |
| India | 2 |
| Hong Kong (S.A.R.) | 2 |
| United Kingdom | 1 |
Where are Research Centres of Viome Life Sciences Patents Located?
10 Best Viome Life Sciences Patents
CN104969071A is the most popular patent in the Viome Life Sciences portfolio. It has received 21 citations so far from companies like Mimid Diagnostics, Cofactor Genomics and Memed Diagnostics.
Below is the list of 10 most cited patents of Viome Life Sciences:
| Publication Number | Citation Count |
| CN104969071A | 21 |
| WO2019209753A1 | 17 |
| CN109416926A | 16 |
| US20190130994A1 | 13 |
| US20210063410A1 | 12 |
| WO2020168015A1 | 8 |
| CN109416360A | 7 |
| WO2018081175A1 | 7 |
| US20170176441A1 | 6 |
| WO2020076874A1 | 4 |
List of Viome Life Sciences Patents
| Viome Life Sciences Patents | Title |
| WO2023141515A1 | Methods For Computational Analysis Of Biological Samples With Machine Learning Analysis And Systems For Same |
| HK40012841A | Protein Biomarker Panels For Detecting Colorectal Cancer And Advanced Adenoma |
| HK1255533A | Protein Biomarker Panels For Detecting Colorectal Cancer And Advanced Adenoma |
| US20210063410A1 | Automated Sample Workflow Gating And Data Analysis |
| US20190257835A1 | Protein Biomarker Panels For Detecting Colorectal Cancer And Advanced Adenoma |
| US20190130994A1 | Mass Spectrometric Data Analysis Workflow |
| US20180100858A1 | Protein Biomarker Panels For Detecting Colorectal Cancer And Advanced Adenoma |
| US20170370937A1 | Protein Biomarker Panels For Detecting Colorectal Cancer And Advanced Adenoma |
| US20170285033A1 | Method For Evaluation Of Presence Of Or Risk Of Colon Tumors |
| US20170176441A1 | Protein Biomarker Profiles For Detecting Colorectal Tumors |
| EP3721232A1 | Robust Panels Of Colorectal Cancer Biomarkers |
| EP3443497A1 | Mass Spectrometric Data Analysis Workflow |
| EP3436831A1 | Biomarker Database Generation And Use |
| EP3281016A1 | Protein Biomarker Panels For Detecting Colorectal Cancer And Advanced Adenoma |
| EP2926138A2 | Method For Evaluation Of Presence Of Or Risk Of Colon Tumors |
| CN111315487A | Marker Analysis For Quality Control And Disease Detection |
| CN110662966A | Protein Biomarker Panels For Detecting Colorectal Cancer And Advanced Adenoma |
| CN109416360A | Biomarker Database Generation And Use |
| CN109416926A | Mass Spectrometric Data Analysis Workflow |
| CN104969071A | Method For Evaluation Of Presence Of Or Risk Of Colon Tumors |
| WO2021195604A3 | Diagnostic For Oral Cancer |
| WO2021119323A1 | Sample Collection Device With Reagent |
| WO2021113152A1 | Detection And Elimination Of Aberrant Cells |
| WO2020247983A1 | Sample Collection Methods And Devices |
| WO2020168015A1 | Personalizing Food Recommendations To Reduce Glycemic Response |
| WO2020150258A1 | Methods And Systems For Detecting Liver Disease |
| WO2020076874A1 | Methods For And Compositions For Determining Food Item Recommendations |
| WO2020051559A1 | Systems And Methods For Microbiome Analysis |
| WO2019209753A1 | Systems And Methods For Inferring Scores For Health Metrics |
| WO2019113239A1 | Robust Panels Of Colorectal Cancer Biomarkers |
| WO2019113563A1 | Methods For Nucleic Acid Library Creation |
| WO2019099574A1 | Methods And Compositions For Preparing Polynucleotide Libraries |
| WO2019050966A3 | Automated Sample Workflow Gating And Data Analysis |
| WO2019050971A1 | Marker Analysis For Quality Control And Disease Detection |
| WO2018232043A1 | Tandem Identification Engine |
| WO2018081175A1 | System And Method For Implementing Meal Selection Based On Vitals, Genotype, And Phenotype |
| GB2545361B | Methods Of Assessing Colorectal Cancer Status |
| IN201917017666A | Protein Biomarker Panels For Detecting Colorectal Cancer And Advanced Adenoma |
| IN201817041006A | Biomarker Database Generation And Use |
What are Viome Life Sciences key innovation segments?
What Technologies are Covered by Viome Life Sciences?
The chart below distributes patents filed by Viome Life Sciences